iShares
BTEC.L
IE00BYXG2H39
iShares Nasdaq US Biotechnology UCITS ETF
Loading chart...

Risk & Diversification Scores

Transparent evaluation of price volatility (SRI) and 4-dimensional portfolio diversification.

Volatility Risk Score
6/7 High
6 / 7 SRI PRIIPs Risk Class

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors.

Volatility (5Y)
21.3% p.a.
5-Year Horizon
Max Drawdown (5Y)
-34.5%
Deepest Drawdown
Sharpe Ratio
0.21
Moderate (0.0 - 0.5)
Rec. Holding Period
10+ Years
Investment Horizon
Speculative / High Risk: Score Basis:
Diversification Score
Focused (35% – 50%)
17 / 100 Portfolio Diversification
4 Dimensions: Holdings (30%) • Sectors (25%) • Industries (25%) • Regions (20%)

Focused weighting: Top holdings drive a major share of fund returns.

Top 10 Holdings
43.8%
Focused
Effective Holdings
~49
of 250 holdings
Top Sector
100.0%
Healthcare
Top Region / Country
88.3%
United States
Elevated concentration in top individual holdings, leading sectors, or key regions.

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +30.5%
3 Years 20.3% -26.8% 0.86 +19.9%
5 Years 21.3% -34.5% 0.21 +6.9%
10 Years 22.3% -38.4% 0.24 —

Notes & Warnings

🟢 Favorable / fair valuation: Avg P/E of 18.2
🟢 Deep market liquidity & capital coverage (Tier 1)
🟢 Established large fund (> 500M € AUM)
🟡 Moderate analyst coverage (16.1 analysts)
🔴 Severe sector concentration risk: 100% in "Healthcare".
🔴 Extreme industry concentration: 68% in "Biotechnology".
🔴 34% of ETF holdings are unprofitable companies (severe cash-burn and fundamental financial risk).
🔴 Growth estimates are hyper-concentrated: Top 3 growth drivers account for 83% of total forward growth.
⚠️ Elevated Regulatory & Policy Risk: 100% in heavily regulated industries (defense, regulated utilities, healthcare policy).
ende